4519 On Other Exchanges
Symbol
Exchange
4519 is not on other exchanges.

Executive Profile*

Yasuo Ikeda

Independent Director,Chugai Pharmaceutical Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 23 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Dr. Yasuo Ikeda serves as a Professor of Department of Life Science and Medical Bioscience of Graduate School of Advanced Science and Engineering of Faculty of Science and Engineering of Waseda University. Dr. Ikeda has been Professor Emeritus of Keio University since 2009. He has been a Vice-Chairman of the Board of Directors at Musashi Academy of the Nezu Foundation since 2013. He has been an Outside Independent Director at Chugai Pharmaceutical Co. Ltd. since 2010. ...

Read Full Background

Corporate Headquarters*

Nihonbashi Mitsui Tower
Tokyo, -- 103-8324

Japan

Phone: 81 3 3281 6611
Fax: 81 3 3281 6607

Board Members Memberships*

2010-Present
Independent Director

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michel Vounatsos Chief Executive Officer and Director
Biogen Inc.
--
Mark J. Alles Chief Executive Officer and Director
Celgene Corporation
$871.3K
Yitzhak Peterburg M.D., Dr.P.H., MSc Interim Chief Executive Officer, Interim President and Director
Teva Pharmaceutical Industries Limited
--
Lars Fruergaard Jørgensen Chief Executive Officer and President
Novo Nordisk A/S
kr8.7M
Stefan Oschmann Chairman of Executive Board and Chief Executive Officer
Merck Kommanditgesellschaft auf Aktien
€4.5M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHUGAI PHARMACEUTICAL CO LTD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.